These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21872518)

  • 1. Insight: prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist: a proposed mechanism and management plan.
    Kauschansky A; Orvieto R; Yeshaya A; Shterntal B; Naor Z
    J Pediatr Adolesc Gynecol; 2011 Dec; 24(6):365-7. PubMed ID: 21872518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist.
    Yeshaya A; Kauschansky A; Orvieto R; Varsano I; Nussinovitch M; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):327-9. PubMed ID: 9539281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J; Reynaud R; Czernichow P
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications of GnRH agonist therapy during childhood].
    Carel JC
    Bull Acad Natl Med; 2012 Feb; 196(2):345-55. PubMed ID: 23420954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on therapy for precocious puberty.
    Wheeler MD
    Compr Ther; 1994; 20(6):351-5. PubMed ID: 8062545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
    N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.
    Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF
    N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone analog therapy for central precocious puberty and other childhood disorders affecting growth and puberty.
    Lee PA; Houk CP
    Treat Endocrinol; 2006; 5(5):287-96. PubMed ID: 17002488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal bleeding in a 4-month-old preterm girl: extreme minipuberty mimicking central precocious puberty.
    de Lange AH; Bocca G
    J Pediatr Endocrinol Metab; 2013; 26(5-6):595-7. PubMed ID: 23640937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and body composition in Thai Precocious Puberty girls treated with GnRH agonist.
    Wacharasindhu S; Petwijit T; Aroonparkmongkol S; Srivuthana S; Kingpetch K
    J Med Assoc Thai; 2006 Aug; 89(8):1194-8. PubMed ID: 17048429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Precocious pubertal].
    Carel JC; Zenaty D; Paulsen A; Simon D; Léger J
    Rev Prat; 2008 Jun; 58(12):1317-23. PubMed ID: 18714652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Gonadotropin-Releasing Hormone Agonist Treatment on Thyroid Function Tests in Children with Central Idiopathic Precocious Puberty.
    Naderi F; Soheilirad Z; Haghshenas Z
    Med Arch; 2019 Apr; 73(2):101-103. PubMed ID: 31391696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists.
    Miller BS; Shukla AR
    Clin Ther; 2010 Sep; 32(10):1749-51. PubMed ID: 21194598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA; Abujamra AC; Minanni SL; Mendonca BB; Nery M; Lerario AC; Pereira MA; Abelin N; Wajchenberg BL
    Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of precocious puberty.
    Wheeler MD; Styne DM
    Endocrinol Metab Clin North Am; 1991 Mar; 20(1):183-90. PubMed ID: 1827623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.